Fujicopian Co., Ltd. (7957) said holders exercised 390 units of its 2nd series stock acquisition rights on Oct. 6, 2026, or 10.26% of the total issued, at an exercise price of ¥1,857, resulting in the delivery of 39,000 new shares.

KOZO Holdings (9973) said 5,000 of the 16th series stock acquisition rights it issued to Macquarie Bank Limited through a third-party allotment were exercised on Oct. 6, 2026, resulting in the delivery of 500,000 new shares at an exercise price of ¥17.0.

Nachi-Fujikoshi Corp. (6474) said on Oct. 5 its board approved a 5-for-1 stock split with a record date of Nov. 30, 2026, and reported nine-month net profit attributable to owners of the parent of ¥6.63 billion, up 82.1% from a year earlier.

Fujicopian Co., Ltd. (7957) said holders exercised 660 units of its second series of share warrants carrying an exercise-price adjustment clause on Oct. 5, 2026, delivering 66,000 new shares at an exercise price of ¥1,999.

Noile-Immune Biotech Inc. (4893) said on Oct. 5 it has received full payment of ¥1.4 million for its 14th series of stock acquisition rights with an exercise price adjustment clause, allotted to Okasan Securities Co., Ltd., covering up to 10 million shares and expected to raise an estimated net ¥1,349.4 million.

ReproCELL Inc. (4978) said its board on Oct. 5 approved the fourth issuance under its equity program with CVI Investments, Inc., selling 2,932,000 new shares at ¥119 each and 29,320 stock acquisition rights exercisable at ¥159 per share, for estimated net proceeds of ¥810.5 million if all rights are exercised.

Media Kobo Inc. (3815) said on Oct. 5, 2026 its board approved issuing 1,028,400 new shares at ¥389 each to ULTIMATE CLASSIC INVESTMENT LLC (UCI) for ¥400,047,600, along with 15,426 fourth-series warrants, and will use the proceeds to redeem early ¥300 million in outstanding convertible bonds.

Gokendo Holdings Co., Ltd. (9146) said its board approved a 3-for-1 split of its common shares with a record date of Oct. 21, 2026, lifting shares outstanding to 3,885,000 from 1,295,000.

BrightPath Bio Co., Ltd. (4594), listed on the Tokyo Stock Exchange Growth market, said on Oct. 5 it has received full payment of ¥2.415 million for its 21st series of stock acquisition rights with an exercise price adjustment clause, allotted to Phillip Capital Securities, which would raise net proceeds of ¥1.95 billion if fully exercised at the initial price of ¥57.

Toshin Holdings (9444), under court-supervised corporate reorganization, disclosed a reorganization plan that would issue 4,884,884 Class A shares at ¥130 each to Sumitomo Mitsui Banking Corp. and other creditors in a debt-for-equity swap valued at an estimated ¥635,034,920.

Fujicopian Co., Ltd. (7957) said holders exercised 780 units of its second series of share warrants on Oct. 1-2, 2026, equal to 20.53% of the total issued, resulting in the delivery of 78,000 shares, all transferred from treasury stock.

Bitcoin Japan (8105) said ¥262.5 million of its first series of unsecured convertible bonds with a conversion price adjustment clause, issued to EVO FUND, were converted in September into 3,432,250 new shares, leaving ¥825 million unconverted at month-end.

Nakayama Seikosho (5408) said on Oct. 2, 2026 it has received full payment of ¥8,693,964,000 from Hanwa Kogyo and Yodoko for 13,054,000 shares issued and sold from treasury at ¥666 each in a third-party allotment.

Genext Co., Ltd. (4179) said its board decided on Oct. 1, 2026 to cancel a planned third-party allotment of new shares and 8th series stock acquisition rights after ADON Co., Ltd., which was to subscribe for 388,300 shares, said it could not pay by the Oct. 1 payment date.

Uchiyama Holdings Co., Ltd. (6059), listed on the Tokyo Stock Exchange Standard Market, said none of its 2nd and 3rd series stock acquisition rights were exercised in September 2026, leaving 4,500 units (450,000 shares) of each series unexercised at month-end.

TORICO Co., Ltd. (7138) said none of its 11th-series stock acquisition rights allotted to EVO FUND were exercised in September 2026, leaving 83,100 units (8.31 million shares) outstanding at month-end.

SymBio Pharmaceuticals Limited (4582) said EVO FUND exercised 43,000 of its 70th series stock acquisition rights in September 2026, receiving 4,300,000 new shares, or 9.0% of the 480,000 rights issued.

Diamond Electric Holdings Co., Ltd. (TSE: 6699) said 600 units of its 8th Series Stock Acquisition Rights, equal to 0.7% of the 85,000 units issued, were exercised in September 2026, resulting in the delivery of 60,000 new shares.

Architects Studio Japan (6085) said on Sept. 29 it will use proceeds from a third-party allotment of its 5th series of stock acquisition rights with an exercise price adjustment clause to shore up its finances and fund growth, targeting sales of ¥4,731 million and operating profit of ¥1,050 million in the fiscal year ending February 2030.

Fujicopian Co., Ltd. (7957) said holders exercised 540 of its second series of third-party-allotted stock acquisition rights with an exercise-price adjustment clause between Sept. 1 and Sept. 29, 2026, equal to 14.21% of the total issued, with all 54,000 shares delivered from treasury stock.

Sanden Corporation (6444) said payment was completed on Sept. 29, 2026 for 510,000 new common shares issued at ¥197 apiece through a third-party allotment to employees, raising ¥100.47 million.

Wellneo Sugar Co., Ltd. (2117) said on Sept. 29, 2026 its board approved disposing of up to 12,000 treasury shares to its employee shareholding association via a third-party allotment at ¥2,859 per share, for a maximum total of ¥34.3 million.

Carna Biosciences (4572) said on Sept. 28 it signed a convertible bond issuance program with Cantor Fitzgerald Europe to raise ¥561.6 million through three private placements of unsecured convertible bonds, and will separately raise about ¥850 million by placing new shares with shareholder Daisuke Gomi and kaya holdings.

WIZE (3664) said on Sept. 28, 2026 that 72,000 of its 39th series stock acquisition rights, issued to EVO FUND via third-party allotment on June 1, 2026, were exercised between Sept. 1 and Sept. 28, or 12.0% of the 600,000 rights issued, leading it to deliver 7,200,000 new shares.

Image Joho Kaihatsu (3803) said on Sept. 28, 2026 it will use ¥170 million (excluding tax) of proceeds from a third-party share allotment to acquire Digross's CRM business, dropping a planned ¥275 million (tax included) purchase of Cybridge Group's social media marketing business.

Architects Studio Japan Inc. (6085) will issue 280,000 moving-strike stock acquisition rights and its first unsecured private-placement bond to EVO FUND, with the warrants set to raise about ¥3.22 billion if fully exercised at the initial price of ¥115.

Yumetenbo Co., Ltd. (3185) said on Sept. 28, 2026, it has received full payment for its 12th series of stock acquisition rights with an exercise-price adjustment clause, which cover 2.17 million common shares and would raise an estimated ¥296.7 million net if fully exercised at the initial price of ¥138.7.

Linkers Corporation (5131) said on Sept. 28, 2026, it had received full payment for 2,136,700 new common shares issued to SBI Holdings, Inc. through a third-party allotment at ¥117 per share, raising ¥249,993,900.

Cuorips Inc. (4894), listed on the Tokyo Stock Exchange Growth market, said it completed payment on Sept. 28, 2026 for 619,700 new shares issued through a third-party allotment at ¥4,841 each, raising ¥2,999,967,700.

Meiko (6787) said its board on Sept. 28 approved a 2-for-1 stock split that will raise its issued shares to 53,606,640 from 26,803,320, effective Nov. 2, 2026.

Kyushu Electric Power Co., Inc. (9508) released a notice regarding the cancellation of treasury shares at 18:15 on Sept. 28, 2026, without stating the number of shares or the cancellation date in the text available.

Kodensha Co., Ltd. (1948), listed on the Tokyo Stock Exchange's Standard Market, said its common shares will be delisted on Sept. 25, 2026, after shareholders approved a share consolidation at an extraordinary general meeting.

Osaka Titanium Technologies Co., Ltd. (5726) said on Sept. 24 it will issue 854,000 new shares in a third-party allotment, fewer than the 1,050,000 shares originally planned, for a total paid-in amount of ¥2.12 billion.

meito (2207) said its board approved a 2-for-1 split of its common stock with a record date of Dec. 31, 2026, taking effect Jan. 1, 2027 and raising total shares issued to 33,303,416.

Miyairi Valve Seisakusho Co., Ltd. (6495) said 9,800 of its third series of stock acquisition rights were exercised between Sept. 10 and Sept. 24, 2026, resulting in the delivery of 980,000 new shares at exercise prices of ¥98.1 to ¥99.0.

Oricon Inc. (4800) said its board resolved on Sept. 24, 2026 to acquire 125,800 of its own shares free of charge on Sept. 25 as it terminates its stock benefit trusts for officers and employees, and to cancel them together with 152 odd-lot shares, a total of 125,952 shares, on Sept. 29.